Raymond James Financial Inc Tiziana Life Sciences LTD Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Raymond James Financial Inc holds 10,000 shares of TLSA stock, worth $6,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$6,300% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
1.08MCall Options Held
19.2KPut Options Held
0-
Geode Capital Management, LLC Boston, MA219KShares$137,7690.0% of portfolio
-
Hsbc Holdings PLC London, X0115KShares$72,6790.0% of portfolio
-
Morgan Stanley New York, NY110KShares$69,1400.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il104KShares$65,7030.0% of portfolio
-
Zhang Financial LLC93.2KShares$58,7070.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $64.4M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...